{"nct_id":"NCT00701415","title":"A Study of Two Fabrazyme (Agalsidase Beta) Dosing Regimens in Treatment-naïve, Male Pediatric Patients Without Severe Symptoms","status":"COMPLETED","status_verified_date":"2016-05","start_date":"2008-09","start_date_type":null,"primary_completion_date":"2015-06","primary_completion_date_type":"ACTUAL","completion_date":"2015-06","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SNY"]}